HIF1A and colorectal cancer: Specific to colorectal cancer, increased activity of transcription factor hypoxia inducible factor 1α (HIF-1a) reduces the efficacy of 5-Fluorouracil, the backbone of chemotherapy in colorectal cancer and a radiosensitizer in the context of concurrent chemoradiotherapy (CRT) [10].